Total Funding
30
Total FundingSeries B raised
Growth Score
pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
MicroBiome Therapeutics is a biotechnology company that develops medical food and pharmaceutical products.
- Dale Pfost: CEO and Co-FounderPast Role: NuMe Health, CEO
About the Company
MicroBiome Therapeutics is a biotechnology company that develops medical food and pharmaceutical products. The company focuses on developing evidence-based microbiome modulators, which are designed to alter bacteria populations and their environment in the gastrointestinal tract in specific ways to treat and prevent serious health conditions. Its
product includes NM504, which contains a combination of prebiotic and other naturally occurring ingredients formulated to help diabetic individuals achieve healthy blood glucose levels and manage their body weight.
MicroBiome Therapeutics was formerly known as NuMe Health LLC. The company was founded in 2009 and is based in Broomfield, Colorado.
